3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Multiple Myeloma
2
Carcinoma, Non-Small-Cell Lung
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Tubular Adenocarcinoma
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Large B-Cell, Diffuse
1
Infections
1
Hemangioma, Cavernous, Central Nervous System
1
Hemangioma
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Gallbladder Cancer Unresectable
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Cancer-Related Condition
1
Cachexia
1
Brenner Tumor
1
Biliary Tract Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Gemcitabine
12
Oxaliplatin
8
Capecitabine
6
apatinib
5
tislelizumab
4
Surgical Procedures, Operative
4
Radiofrequency Ablation
4
Neoadjuvant Therapy
4
Fluorouracil
4
Cisplatin
4
sintilimab
3
lenvatinib
3
Radiotherapy
3
Leucovorin
3
Irinotecan
3
toripalimab
2
regorafenib
2
pembrolizumab
2
camrelizumab
2
Stents
2
Photochemotherapy
2
Immunotherapy
2
Hepatectomy
2
Folfox protocol
2
Everolimus
2
Drug Therapy
2
Cholangiopancreatography, Endoscopic Retrograde
2
Blood Specimen Collection
2
surufatinib
1
pemigatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Cholangiocarcinoma
×
Observation
×
Clear all
NCT04333927
2020-06-23
ACCORD
Sun Yat-sen University
Phase 2
Unknown
92 enrolled